This LabProfiler report presents findings from a market study carried out to identify and profile the global locations of laboratories where Circulating Tumour Cells (CTCs) are studied. Other market areas relating to the study of CTCs in these laboratories were also analysed, including global regions, countries, organisation types, research or clinical use and organisation names.
This study identified 750 organisations where CTCs are being studied. These have been mapped across the Americas, EMEA and Asia Pacific, 9 global regions, 47 countries and the end-user laboratory organisations by name.
LabProfiler studies focus on individual laboratory activities, such as a specific method or application. Other kinds of laboratory activities are also covered in these studies, such as the use of a specific reagent or antibody or the study of a specific disease, protein, biomarker or cell type.
Our goal in conducting LabProfiler studies is to identify a high proportion of all global laboratories where a particular activity of interest is found. Findings from these studies provide a highly cost-effective means by which suppliers can identify new market opportunities.
Our LabProfiler studies are provided in the form of a PDF report, together with an excel study file containing the full market information compiled during the study. This file can be used independently, or imported directly into your own database. The PDF market report analyses the study of CTCs across all areas of the study. If required, further analysis can be carried using the excel data file, for example with Pivot tables. This enables leading global CTC markets and sectors to be identified.
This study investigated global laboratories studying CTCs. The excel data file provided with the report enables further segmentation across these areas of the study.
2. EMEA, Americas, Asia Pacific
Laboratories studying CTCs were profiled across three major global regions, namely EMEA, Americas and Asia Pacific. These findings are segmented by top countries, organisation types and other areas. The excel data file provided with the report enables further segmentation across these areas of the study.
This study also profiled CTC laboratories across 13 global regions and these Europe, North America, Asia, South America, Middle East, Oceania and Northern Africa. The excel data file provided with the report enables further segmentation across these areas of the study.
More than 95 countries were profiled in terms of laboratories studying CTCs and these included China, United States, Germany, Japan, United Kingdom, Italy, Brazil, France, Spain, India, Iran, Canada, Australia, Taiwan, Poland, Sweden, Netherlands, Republic of Korea, Switzerland, Portugal, Denmark, Belgium, Austria, Turkey, Norway, Mexico, Czech Republic, Greece, South Africa and Thailand. The excel data file provided with the report enables further segmentation across these areas of the study.
5. Organisation Types
This study also profiled laboratories across more than 40 organisation types where CTCs are studied. These included hospitals, institutes, universities, companies, agencies, national laboratories and clinical centres. The excel data file provided with the report enables further segmentation across these areas of the study.
6. Research and Clinical Use
Laboratories where CTCs are studied for either research and clinical purposes, were also profiled. The excel data file provided with the report enables further segmentation across these areas of the study.
7. Major Markets
Findings in this study enable major markets to be identified, relating to CTCs. These findings are segmented across all areas of the study.
The year in which CTCs were studied by the laboratories identified in this study, are also included in the findings of this study. These relate to findings over the period 2013 to 2017.
9. Organisation Names
As part of this study we also identified the names and addresses of the organisation studying CTCs. These provide a valuable source of qualified market leads, enabling suppliers to identify new CTC markets and opportunities.